Back to search

Cambridge Nucleomics Ltd

13135667

active
Private Limited Company
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Going concern doubt noted in accounts (-10)

Details

MEDITRINA BUILDING, CAMBRIDGE, CB22 3AT
Incorporated 15/01/2021

Compliance

Last accounts

30/06/2025

total exemption full

Next accounts due

31/03/2027

On track

Confirmation statement

Last: 14/01/2026

Due 28/01/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Dr. Ulrich Felix Keyser

director · Since 17/05/2021

PROFESSOR

GERMAN · ENGLAND · Age 51

Mr Hendrik Friedrich Peter Runge

director · Since 17/10/2022

CEO

GERMAN · ENGLAND · Age 35

Mr John Mark Yeomans

director · Since 03/03/2025

COMPANY DIRECTOR

BRITISH · ENGLAND · Age 69

Also on 2 other boards

Dr Max Zhu

director · Since 06/03/2025

COMPANY DIRECTOR

CHINESE · HONG KONG · Age 44

Dr Anthony Cooke

director · Since 26/01/2026

BRITISH · ENGLAND · Age 70

Also on 8 other boards

Persons with Significant Control

Mr Hendrik Friedrich Peter Runge

25–50% shares
25–50% votes

German · England · Age 35

Meditrina Building, Babraham Research Campus, Cambridge, CB22 3AT

Notified 28/10/2022

Former PSCs

Dr Max Zhu

Ceased 01/08/2022

Dr. Ulrich Felix Keyser

Ceased 03/03/2025

CompanyRankvs 518+ SIC 72110 peers
62

Financial strength88th percentile among SIC peers · 22/25
Employees66th percentile among SIC peers · 10/15
LiquidityCurrent ratio 25.61× · 20/20
Longevity5 years trading (max 15) · 5/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
How is this score calculated?
Financial strength22/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees10/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity5/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

Act 2006. The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £. 2.2. Going Concern Disclosure The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going

Key FinancialsYear ending 30/06/2025

Net Worth

£399k

Balance sheet strength

Cash

£528k

Cash in the bank

Net Current Assets

£527k

Working capital

Current Assets

£549k

Current Liabilities

£21k

Debtors

£21k

2avg. employees

Tax at Year End(2023)

Corp tax£783

Balance Sheet

Assets less current liabilities£527k
Signed by Dr Hendrik Runge 20 March 2026Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
202525.61+£506k
20242.45-£29k
202313.00-£80k

Derived from filed accounts. Not audited figures.